FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas-Reference-Cited by-同舟云学术

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

Published:2012-01 Issue:7379 Volume:481 Page:90-93
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Duan Shanshan,Cermak Lukas,Pagan Julia K.,Rossi Mario,Martinengo Cinzia,di Celle Paola Francia,Chapuy Bjoern,Shipp Margaret,Chiarle Roberto,Pagano Michele

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature10688.pdf

Reference19 articles.

1. Ci, W., Polo, J. M. & Melnick, A. B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr. Opin. Hematol. 15, 381–390 (2008)

2. Staudt, L. M. & Dave, S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv. Immunol. 87, 163–208 (2005)

3. Baron, B. W. et al. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc. Natl Acad. Sci. USA 101, 14198–14203 (2004)

4. Cattoretti, G. et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7, 445–455 (2005)

5. Cardozo, T. & Pagano, M. The SCF ubiquitin ligase: insights into a molecular machine. Nature Rev. Mol. Cell Biol. 5, 739–751 (2004)

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SAMD1 suppresses epithelial–mesenchymal transition pathways in pancreatic ductal adenocarcinoma;PLOS Biology;2024-08-13

2. Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08

3. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6;Journal of Virology;2024-07-23

4. SUMO-specific protease 1 regulates germinal center B cell response through deSUMOylation of PAX5;Proceedings of the National Academy of Sciences;2024-05-22

5. Prognostic value and drug sensitivity of F‑box and leucine‑rich repeat protein 6 in glioma;Oncology Letters;2024-05-14